The Greenfield filter is a small, cone-shaped metal device placed inside the inferior vena cava, the large vein that returns blood from the lower body to the heart, to catch blood clots before they reach the lungs. Developed in the 1970s by surgeon Lazar Greenfield, it became the first widely adopted vena cava filter and remained the gold standard for mechanical prevention of pulmonary embolism for decades. Its conical design, long clinical track record, and unusually low complication profile compared with newer filters make it a reference point against which all subsequent IVC filters are measured.
What the Greenfield Filter Does and How It Works
When a blood clot forms in the deep veins of the legs or pelvis, the danger is that it breaks free, travels through the vena cava, and lodges in the pulmonary arteries. That event, a pulmonary embolism, can be fatal within minutes. Blood thinners are the first-line defense, but some patients cannot take them safely. The Greenfield filter sits inside the vena cava below the kidneys and physically intercepts clots while allowing blood to continue flowing around the trapped material.
The filter’s cone shape is central to how it performs. Blood clots tend to get caught in the center of the cone, where the filter’s wire legs converge. This leaves the outer portion of the vessel open enough for blood to keep moving through, which is critical because a completely blocked vena cava creates its own set of serious problems. The design aims to balance two competing goals: trapping clots large enough to be dangerous while preserving enough flow to prevent the vein itself from clotting shut.
Long-Term Clinical Performance
The Greenfield filter accumulated one of the longest clinical track records of any implantable vascular device. A 20-year review of clinical experience found a recurrent pulmonary embolism rate of about 4% and a vena cava patency rate of 96%, meaning the vast majority of patients kept the vein open and functioning after filter placement.1PubMed. Twenty-year clinical experience with the Greenfield filter Those numbers were striking at the time and set the bar for every filter that followed.
In high-risk trauma patients, the filter showed even more dramatic results when used preventively. A study comparing trauma patients who received a prophylactic Greenfield filter to a control group found that none of the filter patients developed a pulmonary embolism, while 13 patients in the control group did, nine of them fatally.2PubMed. Prophylactic Greenfield filter placement in selected high-risk trauma patients That kind of clear-cut difference in a life-threatening condition cemented the filter’s reputation in trauma care.
Five-year follow-up data on prophylactic filter placement in trauma patients confirmed that the devices could be placed safely with acceptable rates of insertion-related complications and long-term vena cava patency, though patients whose filters were tilted 14 degrees or more, or had struts out of position, remained at higher risk for breakthrough embolism.3Archives of Surgery. Five-Year Follow-up of Prophylactic Vena Cava Filters in High-Risk Trauma Patients
When Doctors Use It
The primary indication has remained consistent since the device was introduced: a patient who has experienced or is at high risk for venous thromboembolism but cannot safely take blood thinners. The most common scenario, historically accounting for about 35% of placements, is a patient with documented blood clots who has a clear contraindication to anticoagulation therapy.4Journal of Vascular Surgery. Current indications for and results of Greenfield filter placement That contraindication could be recent surgery, active bleeding, a bleeding disorder, or a history of dangerous reactions to blood thinners.
Beyond that core use, the filter has been considered in patients whose blood thinners have failed to control clot formation, and in people at extremely high risk who need mechanical protection in addition to medication.5PubMed. Greenfield vena caval filter: rationale and current indications The American College of Chest Physicians has kept the indications fairly narrow, limiting filter use to patients with an absolute contraindication to therapeutic anticoagulation or documented failure of anticoagulation in the setting of an acute clot in a major vein.6Blood. Inferior Vena Cava Filter – Appropriate Use and Retrieval
Stainless Steel Versus Titanium
The original Greenfield filter was made of 304 stainless steel and required a surgical cut-down procedure for placement. As interventional techniques advanced, a titanium version was developed that could be inserted through a smaller catheter delivered through the skin, eliminating the need for a surgical incision.
The titanium version used a beta-3 titanium alloy, and one of its major advantages was MRI compatibility. Testing showed that this alloy produced essentially no ferromagnetic response up to 4.7 Tesla and created no imaging artifacts at 0.35 Tesla, making it one of the best-suited metals for patients who might need MRI scans. By contrast, the stainless steel versions caused severe “black hole” artifacts on MRI, with 304 stainless steel also producing marked image distortion that could make the scans unreadable in the area around the filter.7PubMed. MR imaging artifacts, ferromagnetism, and magnetic torque of intravascular filters, stents, and coils
Clinically, the titanium version held up well. A long-term evaluation found a recurrent pulmonary embolism rate of about 3.5% and a vena cava patency rate of 99% after more than a year, comparable to the original stainless steel device.8Journal of Vascular Surgery. Extended evaluation of the titanium Greenfield vena caval filter An improved stainless steel version with downward-directed hooks was also developed, offering better resistance to migration and penetration of the vessel wall while maintaining clot capture and flow preservation comparable to the original.9PubMed. An improved process for development and testing of vena caval filters: the percutaneous steel Greenfield filter
Complications to Know About
No permanent implant is free of complications, and the Greenfield filter is no exception, though its complication rates have generally been lower than those of many newer devices.
The complications that matter most fall into a few categories:
- Strut perforation: The wire legs of the filter can poke through the wall of the vena cava over time. When filter struts penetrate far enough, they can contact or injure neighboring structures including the aorta, duodenum, and large intestine.10PubMed Central. Perforation of inferior vena cava and duodenum by strut of inferior vena cava filter In one documented case, a ruptured strut penetrated the infrarenal aorta itself.11Journal of Vascular Surgery. Late complication of a Greenfield filter associating caudal migration and perforation of the abdominal aorta by a ruptured strut These events sound alarming, but a CT-based comparison found perforation in only about 2% of Greenfield filters, far lower than the 49% seen with one commonly used retrievable filter (Celect) and 43% with another (Günther Tulip).12Journal of Vascular and Interventional Radiology. Complications of Celect, Günther Tulip, and Greenfield Inferior Vena Cava Filters on CT Follow-up: A Single-Institution Experience
- Thrombosis: Clots can form at the insertion site or within the vena cava itself around the filter. These events occurred with all filter types but were uncommon.13JAMA Internal Medicine. Inferior Vena Cava Filters: Indications, Safety, Effectiveness CT follow-up of stainless steel Greenfield filters documented filter-associated IVC thrombus in roughly 11% of patients and breakthrough pulmonary embolism in about 4%.14PubMed. Greenfield stainless steel vena cava filters on computed tomography follow-up
- Tilting and migration: A filter that shifts position or tilts inside the vena cava can lose some of its clot-catching ability. In vivo testing showed a tendency toward poorer clot-trapping performance when the Greenfield filter was tilted, though the difference was not statistically significant.15PubMed. Thrombus-trapping efficiency of the Greenfield filter in vivo
Why Tilting and Clot Burden Compound Each Other
A tilted filter is not just a matter of poor placement. Research into the fluid mechanics of IVC filters has shown that as a trapped clot grows inside the filter, the forces pushing the filter off-axis increase dramatically. Small and moderate clots produce only minor misalignment between the drag force and the filter’s central axis, around 5 to 11 degrees. But a large clot can cause misalignment of roughly 60 degrees, because the growing mass forces blood into an increasingly constricted, lopsided path around the filter.16Results in Engineering. Mechanical origins of inferior vena cava filter tilt and migration: The interplay of clot burden and exercise-induced pulsatility The practical implication is that clot burden itself becomes a compounding risk factor: a filter that catches a lot of clot material is the one most at risk for tilting further, which in turn could compromise its ability to catch the next clot.
The diameter of the vena cava also matters. Experimental work comparing symmetric and asymmetric limb configurations found no significant difference in capture rate in large venae cavae (over 22 mm), because sheer vessel size was the dominant limiting factor. In smaller venae cavae, symmetric limb distribution did perform better.17Journal of Vascular Surgery. Experimental embolic capture by asymmetric Greenfield filters Across all configurations and vessel sizes, though, the overall successful capture rate in that study was 81%, and the researchers concluded that clinically significant clots were captured regardless of limb configuration in all models of the Greenfield filter then in use.
The Shift to Retrievable Filters and What It Meant for the Greenfield
Starting in the early 2000s, the market shifted heavily toward retrievable IVC filters, devices designed to be removed once the risk of pulmonary embolism passed. The logic was appealing: why leave a metal device permanently inside a patient’s vena cava if the threat is temporary? In practice, many retrievable filters were never actually retrieved, leaving patients with a device that was approved for permanent use but may not have been optimized for it.
A direct comparison of clinical outcomes between permanent and retrievable filters found that both types had similar rates of symptomatic pulmonary embolism (about 4% for permanent filters versus about 5% for retrievable ones still in place), similar rates of symptomatic deep vein thrombosis, and similar rates of symptomatic IVC thrombosis, with no statistically significant differences between the groups.18Journal of Vascular and Interventional Radiology. A Comparison of Clinical Outcomes with Retrievable and Permanent Inferior Vena Cava Filters But the complication profiles diverged over time. While retrievable filters are approved for permanent implantation, they appear to carry higher rates of device-related complications in the long term when left in place compared with permanent filters like the Greenfield.19PubMed Central. Permanent versus Retrievable Inferior Vena Cava Filters: Rethinking the “One-Filter-for-All” Approach to Mechanical Thromboembolic Prophylaxis
The striking difference in perforation rates on CT follow-up illustrates this: the Greenfield filter showed perforation in 2% of cases on imaging, compared with 43% to 49% for two popular retrievable designs over comparable follow-up periods.20Journal of Vascular and Interventional Radiology. Complications of Celect, Günther Tulip, and Greenfield Inferior Vena Cava Filters on CT Follow-up: A Single-Institution Experience Filter fracture was also rare to nonexistent with the Greenfield, while it appeared at low rates in the retrievable designs.
FDA Safety Communications and the Push for Timely Retrieval
Reports of complications from retrievable filters left in place for extended periods prompted the FDA to issue safety communications in 2010 and 2014. The agency noted adverse outcomes including clot formation, recurrent pulmonary embolism, filter migration, erosion or perforation through the IVC wall, and filter fracture with fragment embolization. The 2014 communication specifically recommended that retrievable IVC filters be removed within two months of placement once the patient’s risk of clot-related events had resolved.21Blood. Inferior Vena Cava Filter – Appropriate Use and Retrieval
These advisories were not about the Greenfield filter specifically, which was designed to be permanent from the outset. But they reshaped the broader conversation around IVC filters and made clinicians more cautious about leaving any filter in place longer than needed. Ironically, the complications that prompted the FDA warnings were far more common with the newer retrievable designs than with the older permanent Greenfield. The episode highlighted that a “one filter for all” approach had traded one set of risks for another.
What Happens When a Filter Needs to Come Out
Over time, any IVC filter can become embedded in the vessel wall as tissue grows around the struts. This makes removal far more difficult than simply snaring the filter’s hook with a catheter. Multiple filter struts can become embedded in the endothelium with surrounding tissue overgrowth, sometimes requiring sharp surgical dissection of the overlying tissue for complete explantation.22Indian Journal of Vascular and Endovascular Surgery. Open Surgical Removal of a Perforating Malpositioned Inferior Vena Cava Filter – Case Report and Review of Literature
For filters that standard retrieval techniques cannot dislodge, an excimer laser technique has emerged as a powerful option. In a first-in-human escalation trial of 500 patients whose filters resisted high-force retrieval, laser-assisted removal succeeded in over 99% of cases, including both retrievable-type and permanent-type filters. The average time those filters had been in place was over four years, with the longest exceeding 27 years. The laser approach required significantly less force than conventional attempts and carried a major complication rate of about 2%.23PubMed Central. Laser-Assisted Removal of Embedded Vena Cava Filters: A First-In-Human Escalation Trial in 500 Patients Refractory to High-Force Retrieval A subsequent multicenter study confirmed the results, with technical success rates around 95% and major complication rates of 3% to 4%.24PubMed Central. Safety and Success Rates of Excimer Laser Sheath–Assisted Retrieval of Embedded Inferior Vena Cava Filters
Successful retrieval allowed nearly all patients in the initial trial to stop taking anticoagulation that had been prescribed solely because of the filter, and it resolved filter-related symptoms in the vast majority. For patients living with an old Greenfield filter that is causing problems, these techniques mean that “permanent” no longer necessarily means forever.
Greenfield Filters in Cancer Patients
Cancer patients face an unusually high risk of blood clots, and many cannot take blood thinners because of bleeding risks from their tumors or treatments. A retrospective review from the University of Michigan covering 166 cancer patients who received Greenfield filters found that most had distant metastases at the time of filter placement, and about half experienced cancer recurrence at an average of 20 months, a timing that corresponded with the development of new or recurrent thromboembolic events that led to filter placement. The mean survival in these patients was about 10 months, significantly shorter than patients in the filter registry without cancer.25SAGE Journals (Cardiovascular Surgery). Clinical results of Greenfield filter use in patients with cancer
These numbers reflect the severity of the underlying disease rather than a failure of the filter. The filter does what it is designed to do: prevent fatal pulmonary embolism in a population that is already gravely ill. For many cancer patients, the filter serves as a bridge, keeping them alive long enough to continue treatment rather than dying from a preventable complication. Whether a permanent device like the Greenfield or a retrievable filter makes more sense in this population depends on prognosis. A patient with advanced metastatic disease and months to live likely does not need a retrievable filter, while someone with a curable cancer and temporary contraindication to blood thinners might benefit from having the filter removed later.
CT Monitoring of Long-Dwelling Greenfield Filters
Many patients live with Greenfield filters for years or even decades without routine imaging specifically for the filter. When CT scans are performed, they offer a window into how these devices behave over time. A review of stainless steel Greenfield filters on CT follow-up found perforation in about 19% of patients at an average dwell time of 256 days. None of these perforations caused symptoms, and no strut fractures were documented.26PubMed. Greenfield stainless steel vena cava filters on computed tomography follow-up The gap between the 2% perforation rate reported in the comparative study and the 19% found in this dedicated CT analysis likely reflects differences in how perforation was defined and measured; another study used a threshold of strut extension more than 3 mm beyond the caval wall as the cutoff.27Journal of Vascular and Interventional Radiology. Evaluation of Greenfield Inferior Vena Cava Filter Strut Perforation Over Time Using Computed Tomography
The key clinical distinction is between radiographic perforation, where a strut tip is visible beyond the vessel wall on a scan, and symptomatic perforation, where the patient actually feels or is harmed by it. Radiographic perforation is far more common than symptomatic perforation with Greenfield filters, and patients and doctors who discover incidental strut protrusion on a CT performed for other reasons should not automatically assume the filter is causing harm. That said, any filter showing significant displacement, contact with the aorta or bowel, or associated thrombus warrants closer attention from a vascular specialist.
Novel Filter Concepts Building on the Greenfield Legacy
The Greenfield filter’s conical geometry proved so effective that it became the starting template for newer experimental designs. One line of research has explored adding a helical flow inducer to the cone shape, aiming to create a gentle spiraling motion in the blood as it passes through the filter. The idea is that helical flow might reduce stagnation zones where secondary clots tend to form after the filter traps debris. In experimental testing, the helical design captured nearly all test clots at lower clot volumes, and even at higher clot loads it captured most of the material, with the helical inducer itself contributing to clot trapping.28Scientific Reports. Improvement of hemodynamic performance using novel helical flow vena cava filter design Whether these bench-top improvements will translate to better patient outcomes remains to be seen, but the work reflects an ongoing effort to improve on a device concept that has been saving lives since the 1970s.